Abstract
We thank Li and colleagues for their insightful comments [...]
Funder
Buddhist Dalin Tzu Chi Hospital
Reference8 articles.
1. Li, A.-H., and Chiu, Y.-L. (2023). Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612. J. Clin. Med., 12.
2. Chen, Y.-C., Chen, Y.-C., Chiou, W.-Y., and Yu, B.-H. (2022). Impact of acid suppression therapy on renal and survival outcomes in patients with chronic kidney disease: A Taiwanese nationwide cohort study. J. Clin. Med., 11.
3. Cause-specific deaths in non-dialysis-dependent CKD;Navaneethan;J. Am. Soc. Nephrol.,2015
4. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation;Schmidt;Aliment. Pharmacol. Ther.,2012
5. Meta-analysis: The effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel;Kwok;Aliment. Pharmacol. Ther.,2010